Alternatives to Phendimetrazine If You Can't Fill Your Prescription

Phendimetrazine (formerly sold under the brand name Bontril) is an effective weight-loss medication — but if your pharmacy doesn't have it in stock and you've run out of options, you and your doctor may need to consider alternatives. Fortunately, there are several FDA-approved weight-loss medications that work through similar or complementary mechanisms.

This guide covers the most relevant alternatives to Phendimetrazine in 2026, including how they compare in terms of mechanism, availability, cost, and key differences to discuss with your prescriber.

Important Note Before Switching

Never stop Phendimetrazine abruptly or switch medications without talking to your doctor first. Abrupt cessation after prolonged use can cause withdrawal symptoms including fatigue and depression. Your doctor needs to evaluate your history, health conditions, and goals before recommending an alternative.

Alternative 1: Phentermine (Adipex-P, Lomaira) — Most Available

Phentermine is the most widely prescribed weight-loss medication in the United States and the most pharmacologically similar option to Phendimetrazine. Like Phendimetrazine, it is a sympathomimetic amine that works by stimulating the CNS and suppressing appetite through norepinephrine release.

Key differences: Phentermine is a Schedule IV controlled substance (vs. Schedule III for Phendimetrazine), which gives it somewhat fewer prescription restrictions. It is also considerably more widely available at pharmacies nationwide. Generic Phentermine typically costs $10-$40/month with a discount card.

Best for: Patients who need a short-term stimulant appetite suppressant with broad pharmacy availability and low cost.

Alternative 2: Qsymia (Phentermine/Topiramate ER) — For Longer-Term Use

Qsymia is a combination medication containing phentermine (for appetite suppression) and topiramate extended-release (which enhances satiety and may reduce cravings). It is FDA-approved for chronic weight management, meaning it can be used for longer than the few weeks allowed for Phendimetrazine or phentermine alone.

Key differences: Qsymia is approved for adults with a BMI ≥30 kg/m² or ≥27 kg/m² with at least one weight-related condition. It is also a Schedule IV controlled substance. Cost is higher than generic Phendimetrazine — a generic version by Teva is available, which has significantly reduced prices.

Best for: Patients who have used short-term stimulants and need a longer-term prescription weight-loss option with a proven clinical profile.

Alternative 3: Contrave (Naltrexone/Bupropion) — Non-Stimulant Option

Contrave is a combination of naltrexone (used in addiction medicine) and bupropion (an antidepressant and smoking cessation aid). Rather than stimulating the CNS, Contrave targets the brain's reward and hunger centers to reduce appetite and food cravings. It is not a controlled substance, which makes it easier to prescribe and fill.

Key differences: Contrave is not a stimulant and doesn't carry the same cardiovascular risks or abuse potential as Phendimetrazine. It is approved for long-term use and is generally better tolerated by patients with a history of anxiety or cardiovascular concerns. It is not appropriate for patients with a history of seizures.

Best for: Patients who cannot tolerate stimulant medications or who have mild cardiovascular risk factors that preclude stimulant use.

Alternative 4: GLP-1 Receptor Agonists (Wegovy, Zepbound) — Maximum Weight Loss

GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Zepbound) represent the newest class of weight-loss medications and have demonstrated significantly greater weight loss than older options in clinical trials. They work by mimicking gut hormones that regulate appetite, slowing gastric emptying, and reducing caloric intake.

Key differences: GLP-1 medications require weekly injections (not oral tablets), cost significantly more ($800-$1,500/month without insurance), and have their own availability challenges. They are non-controlled substances approved for long-term use. Insurance coverage is expanding but remains inconsistent.

Best for: Patients with significant obesity (BMI ≥30, or ≥27 with comorbidities) who want maximum weight loss and have insurance coverage or can afford the monthly cost.

Alternative 5: Orlistat (Xenical, Alli) — Non-Stimulant, OTC Option

Orlistat works completely differently from Phendimetrazine — instead of suppressing appetite, it blocks the absorption of dietary fat in the gut by about 30%. It is available in prescription strength (Xenical, 120 mg) and over the counter (Alli, 60 mg). It is not a controlled substance.

Key differences: Orlistat does not affect the CNS and is appropriate for patients who can't use stimulants. It has notable gastrointestinal side effects (oily stools, urgency) that limit tolerability for many patients. It is the only OTC FDA-approved weight-loss medication.

How to Talk to Your Doctor About Switching

When discussing alternatives with your prescriber, be prepared to share:

• How long you've been on Phendimetrazine and your results so far
• Any side effects you experienced
• Your cardiovascular history, blood pressure readings, and other relevant conditions
• Insurance coverage and budget constraints

Finding Whichever Medication You're Prescribed

Whether your doctor keeps you on Phendimetrazine or switches you to an alternative, actually finding it in stock is often the biggest challenge. medfinder helps patients find any weight-loss medication at pharmacies near them by calling ahead to check availability — so you never waste a trip to the pharmacy again.